Lung Carcinomas with EGFR Exon 19 Insertions Are Sensitive to Gefitinib Treatment

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of thoracic oncology 2014-04, Vol.9 (4), p.e31-e33
Hauptverfasser:	Iyevleva, Aglaya G., Mitiushkina, Natalia V., Karaseva, Nina A., Orlov, Sergey V., Volodina, Larisa N., Kulikova, Yulia E., Lozhkina, Alexandra M., Ivantsov, Alexandr O., Tiurin, Vladislav I., Togo, Alexandr V., Imyanitov, Evgeny N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - genetics Adenocarcinoma - pathology Amino Acid Sequence Base Sequence Carcinoma, Large Cell - drug therapy Carcinoma, Large Cell - genetics Carcinoma, Large Cell - pathology Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - genetics Carcinoma, Squamous Cell - pathology Exons - genetics Female Humans Lung Neoplasms - drug therapy Lung Neoplasms - genetics Lung Neoplasms - pathology Middle Aged Molecular Sequence Data Mutagenesis, Insertional - genetics Neoplasm Staging Prognosis Protein Kinase Inhibitors - therapeutic use Quinazolines - therapeutic use Receptor, Epidermal Growth Factor - antagonists & inhibitors Receptor, Epidermal Growth Factor - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!